BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1520354 Paris, I0

Position in IONS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$58,216,223

-$9,930,429 QoQ

Shares Held

734,219

-19.1% QoQ

Ownership

0.442%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#40

of 514 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,299,463 across 137 Biotechnology names. IONS ranks #11 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	897,893	$446,010,389
2	REGN	Regeneron Pharmaceuticals, Inc.	331,560	$206,740,921
3	JAZZ	Jazz Pharmaceuticals plc	799,297	$192,606,596
4	ARGX	Argenx SE	121,786	$112,989,396
5	INCY	Incyte Corp	937,763	$106,304,813
6	XENE	Xenon Pharmaceuticals Inc.	1,290,731	$77,908,522
7	VCEL	Vericel Corp	1,639,988	$72,963,065
8	CYTK	Cytokinetics Inc	827,810	$70,521,132

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$58,216,223	734,219	-19.1%	Shares	Defined	2026-08-13
2026-03-31	$68,146,652	907,533	-32.9%	Shares	Defined	2026-05-14
2025-12-31	$107,022,934	1,352,837	+27.7%	Shares	Defined	2026-02-13
2025-09-30	$69,326,947	1,059,721	-21.6%	Shares	Defined	2025-11-07
2025-06-30	$53,373,228	1,350,879	+12.9%	Shares	Defined	2025-08-06
2025-03-31	$36,095,146	1,196,392	+10.7%	Shares	Defined	2025-05-14
2024-12-31	$37,768,720	1,080,341	+38.6%	Shares	Defined	2025-02-12
2024-09-30	$31,235,622	779,721	-0.1%	Shares	Defined	2024-11-08
2024-06-30	$37,210,687	780,753	+0.3%	Shares	Defined	2024-07-30
2024-03-31	$33,752,005	778,593	+129.2%	Shares	Defined	2024-05-08
2023-12-31	$17,183,753	339,667	—	Shares	Defined	2024-02-09
No filing history on record for this holder in this stock.